DAKT vs. HRMY

Last updated Apr 1, 2026

Compare and contrast key facts about Daktronics, Inc. (DAKT) and Harmony Biosciences Holdings, Inc. (HRMY).

Performance

DAKT vs. HRMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Daktronics, Inc. (DAKT) and Harmony Biosciences Holdings, Inc. (HRMY). The values are adjusted to include any dividend payments, if applicable.

DAKT vs. HRMY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
DAKT Daktronics, Inc.	-1.11%	17.26%	98.82%	200.71%	-44.16%	7.91%	18.78%
HRMY Harmony Biosciences Holdings, Inc.	-25.15%	8.75%	6.53%	-41.38%	29.22%	17.95%	-2.32%

Fundamentals

Market Cap DAKT : $968.27M HRMY : $1.64B
EPS DAKT : $0.56 HRMY : $3.33
PE Ratio DAKT : 34.87 HRMY : 8.41
PEG Ratio DAKT : 0.04 HRMY : 0.08
PS Ratio DAKT : 1.20 HRMY : 1.89
PB Ratio DAKT : 3.30 HRMY : 1.89
Total Revenue (TTM) DAKT : $802.65M HRMY : $868.45M
Gross Profit (TTM) DAKT : $213.67M HRMY : $670.11M
EBITDA (TTM) DAKT : $41.38M HRMY : $238.25M

Returns By Period

In the year-to-date period, DAKT achieves a -1.11% return, which is significantly higher than HRMY's -25.15% return.

DAKT

• 1D: 2.30%
• 1M: -24.17%
• YTD: -1.11%
• 6M: -6.55%
• 1Y: 60.51%
• 3Y*: 51.07%
• 5Y*: 24.91%
• 10Y*: 10.78%

HRMY

• 1D: 4.13%
• 1M: -1.86%
• YTD: -25.15%
• 6M: 1.63%
• 1Y: -15.61%
• 3Y*: -4.98%
• 5Y*: -2.68%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

DAKT vs. HRMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DAKT

DAKT Risk / Return Rank: 77
DAKT Sharpe Ratio Rank: 79
DAKT Sortino Ratio Rank: 78
DAKT Omega Ratio Rank: 76
DAKT Calmar Ratio Rank: 78
DAKT Martin Ratio Rank: 75

HRMY

HRMY Risk / Return Rank: 25
HRMY Sharpe Ratio Rank: 25
HRMY Sortino Ratio Rank: 25
HRMY Omega Ratio Rank: 24
HRMY Calmar Ratio Rank: 28
HRMY Martin Ratio Rank: 25

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DAKT vs. HRMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Daktronics, Inc. (DAKT) and Harmony Biosciences Holdings, Inc. (HRMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DAKT	HRMY	Difference
Sharpe ratio Return per unit of total volatility	1.20	-0.37	+1.57
Sortino ratio Return per unit of downside risk	1.93	-0.24	+2.18
Omega ratio Gain probability vs. loss probability	1.25	0.96	+0.29
Calmar ratio Return relative to maximum drawdown	2.01	-0.45	+2.46
Martin ratio Return relative to average drawdown	4.48	-0.98	+5.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DAKT vs. HRMY - Sharpe Ratio Comparison

The current DAKT Sharpe Ratio is 1.20, which is higher than the HRMY Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of DAKT and HRMY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	DAKT	HRMY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.20	-0.37	+1.57
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.48	-0.05	+0.53
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.23	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	-0.09	+0.28

Correlation

The correlation between DAKT and HRMY is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

DAKT vs. HRMY - Dividend Comparison

Neither DAKT nor HRMY has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DAKT Daktronics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.07%	3.61%	3.78%	3.07%	3.18%	4.59%
HRMY Harmony Biosciences Holdings, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

DAKT vs. HRMY - Drawdown Comparison

The maximum DAKT drawdown since its inception was -92.96%, which is greater than HRMY's maximum drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for DAKT and HRMY.

Drawdown Indicators

	DAKT	HRMY	Difference
Max Drawdown Largest peak-to-trough decline	-92.96%	-68.48%	-24.48%
Max Drawdown (1Y) Largest decline over 1 year	-31.09%	-34.49%	+3.40%
Max Drawdown (5Y) Largest decline over 5 years	-75.69%	-68.48%	-7.21%
Max Drawdown (10Y) Largest decline over 10 years	-82.34%	—	—
Current Drawdown Current decline from peak	-29.50%	-54.01%	+24.51%
Average Drawdown Average peak-to-trough decline	-50.26%	-34.74%	-15.52%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.94%	15.95%	-2.01%

Volatility

DAKT vs. HRMY - Volatility Comparison

Daktronics, Inc. (DAKT) has a higher volatility of 18.64% compared to Harmony Biosciences Holdings, Inc. (HRMY) at 8.18%. This indicates that DAKT's price experiences larger fluctuations and is considered to be riskier than HRMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DAKT	HRMY	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.64%	8.18%	+10.46%
Volatility (6M) Calculated over the trailing 6-month period	33.38%	31.02%	+2.36%
Volatility (1Y) Calculated over the trailing 1-year period	50.64%	41.98%	+8.66%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	52.11%	50.63%	+1.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	46.37%	52.83%	-6.46%

Financials

DAKT vs. HRMY - Profitability Comparison

The chart below illustrates the profitability comparison between Daktronics, Inc. and Harmony Biosciences Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DAKT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Daktronics, Inc. reported a gross profit of 43.63M and revenue of 181.87M. Therefore, the gross margin over that period was 24.0%.

HRMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Harmony Biosciences Holdings, Inc. reported a gross profit of 175.23M and revenue of 243.78M. Therefore, the gross margin over that period was 71.9%.

DAKT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Daktronics, Inc. reported an operating income of 1.92M and revenue of 181.87M, resulting in an operating margin of 1.1%.

HRMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Harmony Biosciences Holdings, Inc. reported an operating income of 38.56M and revenue of 243.78M, resulting in an operating margin of 15.8%.

DAKT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Daktronics, Inc. reported a net income of 3.01M and revenue of 181.87M, resulting in a net margin of 1.7%.

HRMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Harmony Biosciences Holdings, Inc. reported a net income of 59.03M and revenue of 243.78M, resulting in a net margin of 24.2%.